Novel rhodium(I) and ruthenium(II) complexes with the chiral cyclopentadienyl−phosphine bidentate ligand PPFCp have been prepared and characterized crystallographically. The cationic ruthenium−vinylidene complex [Ru(C CHPh)(PPh 3 )(PPFCp)]PF 6, obtained from [RuCl(PPh 3 )(PPFCp)] and phenylacetylene, reacts with 1-buten-3-ol to afford 3-methyl-1-phenyl-4-penten-2-one in moderate yield with moderate enantioselectivity.
No takes yet. Share an insight, caveat, or question.
Nishibayashi et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: